CT
Context Therapeutics Inc
🇺🇸XNAS.CNTXUnited StatesHealthcare
$0.37USDunchanged 0.00 (0%)After-hoursDelayed8:09 PM
Price$0.370.00 (0%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US21077P1084
- CUSIP
- 21077P108
Company
- Employees
- 15
- Headquarters
- Philadelphia, United States
- CEO
- Mr. Martin A. Lehr
Market
- Shares outstanding
- 91.9M
- Market cap
- $34M
Key dates
- Next earnings
- Nov 4, 2026
Highlights
- Market cap
- $33.08M
- EPS LTM
- -$0.48
- P/E LTM
- -1.18
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $00%unchanged year on year
- Net income
- -$45.96M-34.35%down year on year
- Gross margin
- Not reported
- Free cash flow
- -$34.03M-91.75%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.